Nuclear Partnerships and Stock Market Turmoil

This chapter explores a key partnership in the nuclear sector and the lessons gleaned from past collaborations. It also highlights the fallout from Hims and Hers' stock decline following a controversial breakup with Novo Nordisk, raising concerns about deceptive marketing practices and their effects on patient safety.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app